Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity

The aim of the study was to evaluate the effect of resveratrol in doxorubicin-induced cardiac and hepatic toxicity. Doxorubicin was administered once a week throughout the period of 7 weeks with 1.0 or 2.0 mg/kg body weight or concomitantly with resveratrol (20 mg/kg of feed). Heart and liver toxici...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudka, Jaroslaw, Gieroba, Renata, Korga, Agnieszka, Burdan, Franciszek, Matysiak, Wlodzimierz, Jodlowska-Jedrych, Barbara, Mandziuk, Slawomir, Korobowicz, Elzbieta, Murias, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522488/
https://www.ncbi.nlm.nih.gov/pubmed/23258992
http://dx.doi.org/10.1155/2012/606183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522488/
https://www.ncbi.nlm.nih.gov/pubmed/23258992
http://dx.doi.org/10.1155/2012/606183

Ejemplares similares